← All organizations

Salix

For profitContributed to NMEWebsite ↗

Also known as: SALIX | SALIX PHARMS | SALIX PHARMS INC

Phase 1 Phase 2 Phase 3 Phase 4

First marketed drug

First NDA

Last known activity

Oct 7, 2014

Acquired by Bausch Health Companies on Apr 1, 2015

Timeline

1980s

Jan 1, 1989
Salix— Founded

2000s

Aug 10, 2007
fenofibrate— NDA Secondary Org
Oct 31, 2008
mesalamine— Marketing Organization

2010s

Jan 1, 2011
Oceana Therapeutics— Acquired
Dec 31, 2012
crofelemer— NDA Organization
Jan 1, 2013
Santarus— Acquired
Jan 1, 2014
Cosmo Pharmaceuticals— Acquired
Apr 1, 2015
Bausch Health Companies— Acquired By

Drugs by trial phase (5 distinct, 7 trials)

Phase 3 (0 own, 1 via acquisition)

methylene blue

Phase 2 (0 own, 3 via acquisition)

Phase 1 (0 own, 1 via acquisition)

transgenic lymphocyte immunization vaccine

Indications

Approved for

Subsidiaries (3 direct, 4 total across the full acquisition tree)

Details

Founded: Sunnyvale, CA, US Jan 1, 1989
First NDA: Jul 18, 2000
Last known activity: Oct 7, 2014

Designations held

Orphan drug
Fast track
Priority review